A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disorder

Abroad (travel likely)RecruitingPHASE3

Conditions

Alcohol Use Disorder

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Parkway Medical Center, Birmingham, Alabama, United States

    Study coordinator · 205-876-2601
    Contact: Principal Investigator (James Sullivan)
  • Headlands Research - Scottsdale, Scottsdale, Arizona, United States

    Contact: Principal Investigator (Rosika McKinney)
  • Woodland International Research Group, Little Rock, Arkansas, United States

    Study coordinator · 501-221-8681
    Contact: Principal Investigator (George Konis)
  • UCLA Clinical & Translational Research Center (CTRC), Los Angeles, California, United States

    Study coordinator · 310-794-5383
    Contact: Principal Investigator (Lara Ray)
  • Artemis Institute for Clinical Research, San Diego, California, United States

    Study coordinator · 858-278-3647
    Contact: Principal Investigator (Eric Chavez)
  • UCSF Weill Institute for Neurosciences - Substance Use Disorders Clinic - Mission Bay, San Francisco, California, United States

    Contact: Principal Investigator (Khaled Moussawi)
  • Mountain Mind - Denver, Denver, Colorado, United States

    Contact: Principal Investigator (Larry Sanders)
  • Accel Research Sites - Lakeland Clinical Research Unit, Lakeland, Florida, United States

    Study coordinator · 863-940-2087
    Contact: Principal Investigator (James Andersen)
  • K2 Medical Research - Maitland, Maitland, Florida, United States

    Contact: Principal Investigator (Sejal Patel)
  • K2 Medical Research ORLANDO, Maitland, Florida, United States

    Study coordinator · 407-500-5252
    Contact: Principal Investigator (Brandon Lenox)
  • Life Arc Research Centers - Miami, Miami, Florida, United States

    Study coordinator · 305-874-7401
    Contact: Principal Investigator (Damian Casadesus)
  • Wellness Research Center, Miami, Florida, United States

    Study coordinator · 305-300-2623
    Contact: Principal Investigator (Emilio Mantero-Atienza)
  • Life Medical Research Group Corp, Miami Gardens, Florida, United States

    Study coordinator · 305-705-4111
    Contact: Principal Investigator (Rafael Conte)
  • Charter Research - Orlando, Orlando, Florida, United States

    Contact: Principal Investigator (Jorel Martinez)
  • K2 Medical Research - Tampa, Tampa, Florida, United States

    Study coordinator · 813-800-5252
    Contact: Principal Investigator (Kelley Wilson)
  • Re:Cognition Health - Chicago, Chicago, Illinois, United States

    Contact: Principal Investigator (Abid Nazeer)
  • Maryland Treatment Centers - Mountain Manor Treatment Center, Baltimore, Maryland, United States

    Contact: Principal Investigator (Marc Fishman)
  • Maryland Treatment Centers - Avery Road Treatment Center, Rockville, Maryland, United States

    Contact: Principal Investigator (Marc Fishman)
  • Adams Clinical Boston, Boston, Massachusetts, United States

    Contact: Principal Investigator (Darin Dougherty)
  • K2 Medical Research - Foxborough, Foxborough, Massachusetts, United States

    Study coordinator · 401-435-8950
    Contact: Principal Investigator (john stoukides)
  • Adams Clinical Bronx, The Bronx, New York, United States

    Contact: Principal Investigator (Shama Farooq)
  • North Star Medical Research, Middleburg Heights, Ohio, United States

    Contact: Principal Investigator (Mark Woyshville)
  • Penn Medicine: University of Pennsylvania Health System, Philadelphia, Pennsylvania, United States

    Study coordinator · 215-746-1943
    Contact: Principal Investigator (Henry Kranzler)
  • Avera Research Institute - Sioux Falls, Sioux Falls, South Dakota, United States

    Study coordinator · 605-504-3154
    Contact: Principal Investigator (Vivek Anand)
  • UT Southwestern Medical Center, Dallas, Texas, United States

    Study coordinator · 214-645-6950
    Contact: Principal Investigator (Sherwood Brown)
  • Adams Clinical Dallas, DeSoto, Texas, United States

    Contact: Principal Investigator (Benji Kurian)
  • Pillar Clinical Research - Richardson, Richardson, Texas, United States

    Study coordinator · 214-396-4844
    Contact: Principal Investigator (Scott Bartley)
  • Alpine Research Organization, Clinton, Utah, United States

    Study coordinator · 801-928-3292
    Contact: Principal Investigator (Michael Roundy)
  • Re:Cognition Health, Fairfax, Virginia, United States

    Contact: Principal Investigator (Scott Williams)
  • University of Washington Medical Center - Montlake, Seattle, Washington, United States

    Contact: Principal Investigator (Mark Duncan)
  • ANIMA Research, Diepenbeek, Belgium

    Study coordinator · 003211316272
    Contact: Principal Investigator (Erik Buntinx)
  • Kormont, Kluisbergen, Belgium

    Study coordinator · 32 496 376259
    Contact: Principal Investigator (Klaas Vercruysse)
  • Gezondheidshuis De Gloed, Machelen, Belgium

    Study coordinator · 32 496 376259
    Contact: Principal Investigator (Klaas Vercruysse)
  • Meclinas, Mechelen, Belgium

    Study coordinator · 003215792797
    Contact: Principal Investigator (Claudia Cornelis)
  • Medisch Centrum Saffrou, Oudenaarde, Belgium

    Study coordinator · 32 496 376259
    Contact: Principal Investigator (Klaas Vercruysse)
  • Beijing Anding Hospital - Affiliated Capital University of Medical Science, Beijing, China

    Contact: Principal Investigator (Xiaomeng Xing)
  • Beijing HuiLongGuan Hospital, Beijing, China

    Contact: Principal Investigator (Yunlong Tan)
  • The Second People's Hospital of Hunan Province, Changsha, China

    Contact: Principal Investigator (Xuhui Zhou)
  • The Second Xiangya Hospital of Central South University, Changsha, China

    Contact: Principal Investigator (Wei Hao)
  • West China Hospital, Sichuan University, Cheng Du Shi, China

    Study coordinator · 18980601715
    Contact: Principal Investigator (Jing Li)
  • The Fourth People's Hospital of Chengdu, Chengdu, China

    Study coordinator · +86 13458529130
    Contact: Principal Investigator (Xi Tan)
  • Guangzhou Brain Hospital, Guangzhou, China

    Contact: Principal Investigator (Ni Fan)
  • The Seventh People's Hospital of Hangzhou, Hangzhou, China

    Study coordinator · 86-0571-85127129
    Contact: Principal Investigator (Wanjun Guo)
  • Sir Run Run Shaw Hospital of Zhejiang University School of Medicine, Hangzhou, China

    Contact: Principal Investigator (Jinsong Tang)
  • The Fourth Hospital of Harbin Medical University, Harbin, China

    Contact: Principal Investigator (Leijing Zhang)
  • Huzhou Third Municipal Hospital, Huzhou, China

    Contact: Principal Investigator (Mincai Qian)
  • Shandong Mental Health Center, Jinan, China

    Contact: Principal Investigator (Wei Yuan)
  • First Affiliated Hospital of Kunming Medical University, Kunming, China

    Contact: Principal Investigator (Jin Lu)
  • The Third Hospital of Mianyang, Mianyang, China

    Contact: Principal Investigator (Guangyong Zhang)
  • The First Affiliated Hospital of Nanchang University, Nanchang, China

    Contact: Principal Investigator (Tao Luo)
  • The Affilicated Kangning Hospital of Ningbo University, Ningbo, China

    Contact: Principal Investigator (Haihang Yu)
  • Shanghai Mental Health Center, Shanghai, China

    Contact: Principal Investigator (Jiang Du)
  • Shenzhen Kangning Hospital, Shenzhen, China

    Contact: Principal Investigator (Mei Yang)
  • The First Hospital of Hebei Medical University, Shijiazhuang, China

    Contact: Principal Investigator (Qifeng Zhu)
  • The Affiliated hospital of Southwest Medical University, Sichuan, China

    Contact: Principal Investigator (Kezhi Liu)
  • Tianjin Anding Hospital, Tianjin, China

    Contact: Principal Investigator (Yonghui Zhang)
  • Wuhu Hospital of Beijing Anding hospital, Wuhu, China

    Contact: Principal Investigator (Changqing Hu)
  • Xi An Mental Health Center, Xi'an, China

    Contact: Principal Investigator (Guibin Li)
  • Xiamen Xianyue Hospital, Xiamen, China

    Contact: Principal Investigator (Yan Qiu)
  • Xianyang Hospital of Yan'an University, Xianyang, China

    Contact: Principal Investigator (Xiaoke Hu)
  • Psychiatric Hospital of Henan Province, Xinxiang, China

    Contact: Principal Investigator (Dan Wang)
  • Zhenjiang Mental Health Center, Zhenjiang, China

    Study coordinator · 13952852603
    Contact: Principal Investigator (Zhoubing Wang)
  • FutureMeds GmbH, Berlin, Germany

    Study coordinator · +49 30 439741 239
    Contact: Principal Investigator (Peter Hahn)
  • Velocity Clinical Research, Berlin, Berlin, Germany

    Study coordinator · 493020859400
    Contact: Principal Investigator (Isabelle Schenkenberger)
  • Klinische Forschung Dresden, Dresden, Germany

    Study coordinator · 00493512052780
    Contact: Principal Investigator (Peter Heymer)
  • Klinische Forschung Hamburg, Hamburg, Germany

    Study coordinator · 49404607630
    Contact: Principal Investigator (Christian Deckert)
  • Zentralinstitut für Seelische Gesundheit, Mannheim, Germany

    Study coordinator · 00496211703-3888
    Contact: Principal Investigator (Patrick Bach)
  • Dedicated Research Site FutureMeds, Offenbach, Germany

    Study coordinator · 004969 247 433 840
    Contact: Principal Investigator (Florieke Berfelo)
  • Klinische forschung Schwerin GmbH, Schwerin, Germany

    Study coordinator · 0049385557740
    Contact: Principal Investigator (Christine Paschen)
  • Tokyo-Eki Center-building Clinic, Chūōku, Japan

    Study coordinator · 81120023812
    Contact: Principal Investigator (Arihiro Kiyosue)
  • Ai Sakura Clinic, Fukuoka, Japan

    Study coordinator · 81120023812
    Contact: Principal Investigator (Masamiki Kimura)
  • Hiro Mental Clinic, Fukuoka, Japan

    Study coordinator · 81120023812
    Contact: Principal Investigator (Hiroaki Furui)
  • Kuramitsu Hospital, Fukuoka, Japan

    Study coordinator · 81120023812
    Contact: Principal Investigator (Noriko Tamaru)
  • Rainbow and Sea Hospital, Karatsu, Japan

    Study coordinator · 81120023812
    Contact: Principal Investigator (Taro Shindo)
  • Kariya Hospital, Kariya, Japan

    Study coordinator · 81120023812
    Contact: Principal Investigator (Yasuhiro Kakita)
  • Tatsuta Clinic, Kobe, Japan

    Study coordinator · 81120023812
    Contact: Principal Investigator (Kenji Tatsuta)
  • Arata Clinic, Nagasaki, Japan

    Study coordinator · 81120023812
    Contact: Principal Investigator (Takatoshi Mori)
  • Yokogawa Ekimae Clinic, Nishi, Japan

    Study coordinator · 81120023812
    Contact: Principal Investigator (Ariyuki Kagaya)
  • Teine Keijinkai Hospital, Sapporo, Japan

    Study coordinator · 81120023812
    Contact: Principal Investigator (Tomohiro Shirasaka)
  • Sangenjaya Shinkeika Shinryonaika Clinic, Setagaya City, Japan

    Study coordinator · 81120023812
    Contact: Principal Investigator (Jun Matsushima)
  • Hillside Clinic Jingumae, Shibuya City, Japan

    Study coordinator · 81120023812
    Contact: Principal Investigator (Masayoshi SONE)
  • Kaedenomori Mental Clinic, Shibuya City, Japan

    Study coordinator · 81120023812
    Contact: Principal Investigator (Keiko Koyama)
  • Samoncho Clinic, Shinjuku, Japan

    Study coordinator · 81120023812
    Contact: Principal Investigator (Takahiro Yokoyama)
  • Keiai Clinic, Shinjuku-ku, Japan

    Study coordinator · 81120023812
    Contact: Principal Investigator (Yoshinori Horie)
  • Higashi Shinjuku Clinic, Shinjuku-ku, Japan

    Study coordinator · 81120023812
    Contact: Principal Investigator (Hiroaki Kondo)
  • Sakurazaka Clinic SophyAnce, Tokyo, Japan

    Study coordinator · 81120023812
    Contact: Principal Investigator (Haruhito Muto)
  • Noguchi Naika Clinic, Tokyo, Japan

    Study coordinator · 81120023812
    Contact: Principal Investigator (Yoshimasa Noguchi)
  • Tsukuba University Hospital, Tsukuba, Japan

    Study coordinator · 81120023812
    Contact: Principal Investigator (Hisashi Yoshimoto)
  • Maekawa Medical Clinic, Yokohama, Japan

    Study coordinator · 81120023812
    Contact: Principal Investigator (Hiromitsu Maekawa)
  • National Hospital Organization Hizen Psychiatric Medical Center, Yoshinogari-cho, Kanzaki-gun, Japan

    Study coordinator · 81120023812
    Contact: Principal Investigator (Kazunori Matsuguchi)
  • Hallym University Sacred Heart Hospital, Anyang-si, South Korea

    Contact: Principal Investigator (Kyung Hee Park)
  • Pusan National University Yangsan Hospital, Busan, South Korea

    Study coordinator · 82-55-360-2860
    Contact: Principal Investigator (Sang Yeoup Lee)
  • Chungbuk National University Hospital, Cheongju-si, South Korea

    Contact: Principal Investigator (Joon Hyung Jung)
  • Hanyang University Guri Hospital, Guri-si, South Korea

    Contact: Principal Investigator (Sangmo Hong)
  • Kyungpook National University Hospital, Junggu, South Korea

    Contact: Principal Investigator (Hae-Jin Ko)
  • Gachon University Gil Medical Center, Namdong-gu, South Korea

    Study coordinator · +82-32-458-2778
    Contact: Principal Investigator (Kyoung-Kon Kim)
  • Konyang University Hospital, Seogu, South Korea

    Contact: Principal Investigator (Jee Hyun Kang)
  • Konyang University Hospital, Seogu, South Korea

    Contact: Principal Investigator (Hong Seok Oh)
  • Seoul National University Bundang Hospital, Seongnam, South Korea

    Contact: Principal Investigator (Kiheon Lee)
  • Seoul National University Hospital, Seoul, South Korea

    Contact: Principal Investigator (BeLong Cho)
  • Severance Hospital, Yonsei University Health System, Seoul, South Korea

    Contact: Principal Investigator (Byung Wan Lee)
  • Hanyang University Seoul Hospital, Seoul, South Korea

    Contact: Principal Investigator (Sungwon Roh)
  • The Catholic Univ. of Korea Seoul St. Mary's Hospital, Seoul, South Korea

    Contact: Principal Investigator (Daijin Kim)
  • The Catholic University of Korea, Uijeongbu St. Mary's Hospital, Uijeongbu-si, South Korea

    Contact: Principal Investigator (Hae Kook Lee)
  • Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien City, Taiwan

    Contact: Principal Investigator (Shao-Tsu Chen)
  • China Medical University Hospital, Taichung, Taiwan

    Contact: Principal Investigator (Wan-Ju Cheng)
  • Mackay Memorial Hospital, Taipei, Taiwan

    Contact: Principal Investigator (Chen-Ju Lin)
  • Taipei City Hospital - Songde Branch, Taipei, Taiwan

    Contact: Principal Investigator (Ming-Chyi Huang)
  • Tri-Service General Hospital, Taipei, Taiwan

    Contact: Principal Investigator (San-Yuan Huang)
  • Chang Gung Medical Foundation-Linkou Branch, Taoyuan, Taiwan

    Contact: Principal Investigator (Huang-Li Lin)
  • Layton Medical Centre, Blackpool, United Kingdom

    Study coordinator · 441253951943
    Contact: Principal Investigator (Rebecca Clark)
  • St Pancras Clinical Research - Chester, Chester, United Kingdom

    Study coordinator · 07817649784
    Contact: Principal Investigator (Miho Tsuda)
  • St Pancras Clinical Research - Eastbourne, Eastbourne, United Kingdom

    Study coordinator · 02038651142
    Contact: Principal Investigator (Ward Lawrence)
  • Edinburgh Royal Infirmary, Edinburgh, United Kingdom

    Study coordinator · 07958777103
    Contact: Principal Investigator (Donald MacIntyre)
  • Queen Elizabeth University Hospital, Glasgow, United Kingdom

    Study coordinator · (+44) 0141 232 7600
    Contact: Principal Investigator (Nagore Penades)
  • St Pancras Clinical Research, London, United Kingdom

    Study coordinator · 020 3865 1142
    Contact: Principal Investigator (Graham Campbell)
  • National Institute for Health Research (NIHR) - King's Clinical Research Facility (CRF), London, United Kingdom

    Contact: Principal Investigator (Irene Guerrini)
  • Clerkenwell Health - London - Baker Street, London, United Kingdom

    Contact: Principal Investigator (Alishah Suleman)
  • Greater Manchester Mental Health NHS Foundation Trust, Manchester, United Kingdom

    Contact: Principal Investigator (Stephen Kaar)
  • Southampton General Hospital, Southampton, United Kingdom

    Contact: Principal Investigator (Julia Sinclair)
Study leads
  • Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST)

    Study Director

    Eli Lilly and Company